Literature DB >> 18326136

A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy.

J J Ke1, J Zhan, X B Feng, Y Wu, Y Rao, Y L Wang.   

Abstract

The aim of the study was to investigate the effects of two anaesthetic techniques (total intravenous technique vs. inhalational technique) on changes in pro- and anti-inflammatory cytokine levels during open cholecystectomy. Forty ASA PS I-II patients undergoing open cholecystectomy were randomly assigned to two groups. Group R received total intravenous anaesthesia with propofol and remifentanil and group F received balanced inhalational anaesthesia with isoflurane. The plasma levels of tumour necrosis factor-alpha (TNF-alpha), interleukin IL-6 and interleukin IL-10 were measured during and after surgery. The pro-inflammatory cytokine levels (TNF-alpha and IL-6) and the anti-inflammatory cytokine (IL-10) showed a significant increase in their concentrations compared with pre-induction levels in both groups (P < 0.05). By the end of anaesthesia and surgery, TNF-alpha and IL-6 were significantly lower in group R than in group F (P < 0.05). At the end of anaesthesia and 12 hours postoperatively, IL-10 levels in group R were higher than in group F (P < 0.05). These findings suggest that total intravenous anaesthesia using propofol and remifentanil suppresses the inflammatory response caused by surgery to a greater extent than a balanced inhalation technique using isoflurane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326136     DOI: 10.1177/0310057X0803600113

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  39 in total

1.  Cytokine profile in patients undergoing minimally invasive surgery with balanced anesthesia.

Authors:  José Eduardo B Orosz; Mariana G Braz; Márjorie A Golim; Márcio Antônio A Barreira; Denise Fecchio; Leandro G Braz; José Reinaldo C Braz
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

2.  Comparison of inflammatory cytokine profiles in plasma of patients undergoing otorhinological surgery with propofol or isoflurane anesthesia.

Authors:  Marina Azer Mazoti; Mariana Gobbo Braz; Márjorie de Assis Golim; Leandro Gobbo Braz; Norimar Hernandes Dias; Daisy Maria Favero Salvadori; José Reinaldo Cerqueira Braz; Denise Fecchio
Journal:  Inflamm Res       Date:  2013-06-22       Impact factor: 4.575

Review 3.  [Influence of anesthesia procedure on malignant tumor outcome].

Authors:  K Fukui; C Werner; G Pestel
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

4.  Remifentanil temporarily improves renal function in adult patients with chronic kidney disease undergoing orthopedic surgery.

Authors:  Takerou Terashi; Akihiko Takehara; Tamotsu Kuniyoshi; Akira Matsunaga; Kouichi Kawasaki; Yuuichi Kanmura
Journal:  J Anesth       Date:  2013-02-15       Impact factor: 2.078

Review 5.  Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients.

Authors:  Michael A Smith; Maho Hibino; Bonnie A Falcione; Katherine M Eichinger; Ravi Patel; Kerry M Empey
Journal:  Ann Pharmacother       Date:  2013-11-04       Impact factor: 3.154

6.  Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Xiaoping Chen; Stephen Tomlinson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-01       Impact factor: 1.232

Review 7.  Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery?

Authors:  Hidetomo Niwa; David J Rowbotham; David G Lambert; Donal J Buggy
Journal:  J Anesth       Date:  2013-05-14       Impact factor: 2.078

8.  Remifentanil attenuates lipopolysaccharide-induced acute lung injury by downregulating the NF-κB signaling pathway.

Authors:  Ying Zhang; Zhaohui Du; Qing Zhou; Yanlin Wang; Jianguo Li
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Protective effects of remifentanil on septic mice.

Authors:  Zhang Zongze; Zhan Jia; Chen Chang; Chen Kai; Wang Yanlin
Journal:  Mol Biol Rep       Date:  2009-09-15       Impact factor: 2.316

10.  Remifentanil suppresses increase in interleukin-6 mRNA in the brain by inhibiting cyclic AMP synthesis.

Authors:  Shigeru Maeda; Tsugunobu Andoh; Rieko Onishi; Yumiko Tomoyasu; Hitoshi Higuchi; Takuya Miyawaki
Journal:  J Anesth       Date:  2018-08-30       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.